Estrogen-Containing Oral Contraceptive Agents
作者： Stanford Wessler
DOI: 10.1001/JAMA.1976.03270200017021
关键词:
摘要: Since studies on the effects of oral contraceptives (OCs) antithrombin 3 have been conflicting thrombogenic estrogen were studied in 57 OC users and 48 controls focusing level activated factor X (Xa). The women aged 18-45 (average age for both groups 24). Mean activity was 101 test group 103 control. However Xa levels 85% but only 74% (p < .001). 16% contrasted to 4% had below 60% point at which clotting risk is considered high. Heparin sodium (.1 unit/ml plasma) raised 84% among brought readings up about 50% deficient patients. .25 units or above Antithrombin remained unchanged. It suggested that measurements can identify thrombosis be used who must undergo emergency surgery undergone trauma.
sci-hub.se 参考文章(16)
E. Thye Yin, Linda Eisenkramer, Janet V. Butler, Heparin Interaction with Activated Factor X and Its Inhibitor Advances in Experimental Medicine and Biology. ,vol. 52, pp. 239- 242 ,(1975) , 10.1007/978-1-4684-0946-8_19
Ewa Marciniak, Claude H. Farley, Philip A. DeSimone, Familial Thrombosis Due to Antithrombin III Deficiency Blood. ,vol. 43, pp. 219- 231 ,(1974) , 10.1182/BLOOD.V43.2.219.219
E.T. Yin, S. Wessler, Pamela J. Stoll, Biological Properties of the Naturally Occurring Plasma Inhibitor to Activated Factor X Journal of Biological Chemistry. ,vol. 246, pp. 3703- 3711 ,(1971) , 10.1016/S0021-9258(18)62184-2
E. von Kaulla, W. Droegemueller, N. Aoki, K.N. von Kaulla, Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives American Journal of Obstetrics and Gynecology. ,vol. 109, pp. 868- 873 ,(1971) , 10.1016/0002-9378(71)90799-X
M. P. Vessey, R. Doll, A. S. Fairbairn, G. Glober, Postoperative Thromboembolism and the Use of Oral Contraceptives BMJ. ,vol. 3, pp. 123- 126 ,(1970) , 10.1136/BMJ.3.5715.123
M. K. Fagerhol, U. Abildgaard, Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. Scandinavian Journal of Haematology. ,vol. 7, pp. 10- 17 ,(2009) , 10.1111/J.1600-0609.1970.TB01862.X
Sanford N Gitel, Stanford Wessler, Plasma antithrombin III: a quantitative assay of biological activity. Thrombosis Research. ,vol. 7, pp. 5- 16 ,(1975) , 10.1016/0049-3848(75)90119-X
K.M. McGrath, P.A. Castaldi, Changes in coagulation factors and platelet function in response to progestational agents. Pathophysiology of Haemostasis and Thrombosis. ,vol. 4, pp. 65- 72 ,(1975) , 10.1159/000214089
Ulla Hedner, Inga Marie Nilsson, Antithrombin III in a clinical material Thrombosis Research. ,vol. 3, pp. 631- 641 ,(1973) , 10.1016/0049-3848(73)90011-X
G R Greene, P E Sartwell, Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection. American Journal of Public Health. ,vol. 62, pp. 680- 685 ,(1972) , 10.2105/AJPH.62.5.680